Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 1
1991 2
1992 5
1997 3
1998 2
1999 1
2000 5
2001 2
2002 1
2003 16
2004 9
2005 24
2006 14
2007 15
2008 14
2009 16
2010 11
2011 19
2012 24
2013 15
2014 17
2015 9
2016 17
2017 10
2018 21
2019 12
2020 16
2021 23
2022 17
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

296 results
Results by year
Filters applied: . Clear all
Page 1
Switching from Insulin Degludec plus Dipeptidyl Peptidase-4 Inhibitor to Insulin Degludec/Liraglutide Improves Glycemic Variability in Patients with Type 2 Diabetes: A Preliminary Prospective Observation Study.
Oe Y, Nomoto H, Nakamura A, Kuwabara S, Takahashi Y, Yasui A, Izumihara R, Miya A, Kameda H, Cho KY, Atsumi T, Miyoshi H. Oe Y, et al. Among authors: miya a. J Diabetes Res. 2022 Jan 19;2022:5603864. doi: 10.1155/2022/5603864. eCollection 2022. J Diabetes Res. 2022. PMID: 35097130 Free PMC article.
Favorable effect of sodium-glucose cotransporter 2 inhibitor, dapagliflozin, on non-alcoholic fatty liver disease compared with pioglitazone.
Cho KY, Nakamura A, Omori K, Takase T, Miya A, Yamamoto K, Nomoto H, Kameda H, Taneda S, Kurihara Y, Aoki S, Atsumi T, Miyoshi H. Cho KY, et al. Among authors: miya a. J Diabetes Investig. 2021 Jul;12(7):1272-1277. doi: 10.1111/jdi.13457. Epub 2020 Dec 2. J Diabetes Investig. 2021. PMID: 33131199 Free PMC article. Clinical Trial.
Lymphocytic panhypophysitis and anti-rabphilin-3A antibody with pulmonary sarcoidosis.
Takahashi Y, Kameda H, Miya A, Nomoto H, Cho KY, Nakamura A, Nishimura H, Kimura H, Suzuki M, Konno S, Shimizu A, Matsuno Y, Okamoto M, Motegi H, Iwata N, Fujisawa H, Suzuki A, Sugimura Y, Miyoshi H, Atsumi T. Takahashi Y, et al. Among authors: miya a. Pituitary. 2022 Apr;25(2):321-327. doi: 10.1007/s11102-021-01200-0. Epub 2022 Jan 28. Pituitary. 2022. PMID: 35088194
Effects of switching from a dipeptidyl peptidase-4 inhibitor to oral semaglutide on glucose metabolism in patients with type 2 diabetes: protocol for a multicentre, prospective, randomised, open-label, parallel-group comparison study (the SWITCH-SEMA 2 study).
Nomoto H, Furusawa S, Nakamura A, Takeuchi J, Nagai S, Yokoyama H, Sakuma I, Taneda S, Kurihara Y, Aoki S, Miya A, Kameda H, Cho KY, Atsumi T, Miyoshi H. Nomoto H, et al. Among authors: miya a. BMJ Open. 2022 May 18;12(5):e056885. doi: 10.1136/bmjopen-2021-056885. BMJ Open. 2022. PMID: 35584872 Free PMC article.
296 results